GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. Long Term Debt 2019–2025
GeneDx Holdings Corp. annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- GeneDx Holdings Corp. long term debt as of December 31, 2025: 54.5M, a 2.17% decrease year-over-year.
- GeneDx Holdings Corp. long term debt for 2025 were 54.5M, a 2.17% decrease from 2024.
- GeneDx Holdings Corp. long term debt for 2024 were 55.8M, a 0.88% decrease from 2023.
- GeneDx Holdings Corp. long term debt for 2023 were 56.3M, a 411.36% increase from 2022.
- GeneDx Holdings Corp. long term debt for 2022 were 11.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| GeneDx Holdings Corp. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $55 |
| 2024 | $56 |
| 2023 | $56 |
| 2022 | $11 |
| 2021 | $11 |
| 2020 | $19 |
GeneDx Holdings Corp. Long Term Debt — FAQ
GeneDx Holdings Corp. (WGS) long term debt over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WGS's long term debt history?
The chart and table above show GeneDx Holdings Corp.'s long term debt by year and by quarter, including the growth rate.